Many giant drugmakers are nonetheless utilizing a decades-old take a look at — derived from horseshoe crabs — as a go-to device for detecting contamination in medicines and vaccines, reasonably than switching to a less expensive and equally efficient different, based on a survey by environmental teams.
At challenge are endotoxin exams, that are used to detect bacterial contamination in intravenous medicine and vaccines. The pharmaceutical trade has lengthy relied on a take a look at that makes use of a protein referred to as LAL taken from the blood of American horseshoe crabs, however that is controversial as a result of the crabs are more and more susceptible. Activists say greater than 1.1 million are bled yearly for pharmaceutical functions.
Environmental teams have pushed drugmakers to undertake an artificial different referred to as recombinant issue, or rFC, as a result of the take a look at is believed to be cheaper, extra environment friendly and, typically, extra correct than the older LAL take a look at. However corporations that use the newer take a look at have beforehand complained about added work to validate outcomes earlier than submitting advertising functions to the Meals and Drug Administration.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
